[1. Murray MD, Haag KM, Black P.K, Hall SD, Brater DC. Variable furosemide absorption and poor predictability of response in elderly patients. Pharmacotherapy. 1997; 17:98-106.]Search in Google Scholar
[2. Johnson CE, Wagner DS, Bussard WE. Stability of dolasetron in two liquid vehicles. Am J Health Syst Pharm. 2003; 60:2242-4.10.1093/ajhp/60.21.2242]Search in Google Scholar
[3. Johnson CE, Price J, Hession JM. Stability of norfloxacin in an extemporaneously prepared oral liquid. Am J Health Syst Pharm. 2001; 58:577-9.10.1093/ajhp/58.7.577]Search in Google Scholar
[4. Mills CD, Whitworth C, Rybak LP, Henley CM. Qualification of furosemide from serum and tissue using high-performance liquid chromatography. J Chromatogr B.1997; 701:65-70.10.1016/S0378-4347(97)00341-1]Open DOISearch in Google Scholar
[5. Arulanantham K, Genel M. Central nervous system toxicity associated with ingestion of propylene glycol. J Pediat.1978; 93:515-16.10.1016/S0022-3476(78)81183-4]Open DOISearch in Google Scholar
[6. Standing JF, Tuleu C. Paediatric formulations - getting to the heart of the problem. Int J Pharm. 2005; 300: 56-66.10.1016/j.ijpharm.2005.05.006]Open DOISearch in Google Scholar
[7. Connors KA, Amidon GL, Stella VJ. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists. 2 nd ed. New York:John Wiley & Sons, 1986; p. 474-7.]Search in Google Scholar
[8. Bundgaard H, Norgaard T, Nielson NM. Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int J Pharm. 1988; 42:217-24.10.1016/0378-5173(88)90178-0]Open DOISearch in Google Scholar
[9. Long PF. Microbiological tests on oral pediatric medicines - requirements for an improved Pharmacopoeia monograph. Ann Pharmacother. 2006; 40:158-9.10.1345/aph.1G34916368921]Search in Google Scholar
[10. The United States Pharmacopeia 30 / National Formulary 25. Asian edition. Rockville:The United States Pharmaceutical Convention Inc, 2007; p. 1, 83-9, 585-8.]Search in Google Scholar
